Rein Therapeutics, Inc. · NASDAQ:RNTX
Voss Capital, LP reported a 11.30% stake in Rein Therapeutics, Inc. (Schedule 13G/A)
Event Sep 24, 2025 · Filed Sep 26, 2025
Voss Capital, LP reported a 11.30% stake in Rein Therapeutics, Inc., 2,666,532 shares, as a passive investor on Sep 24, 2025. Filed Sep 26, 2025 (Schedule 13G/A).
- Stake
- 11.30%
- Shares
- 2,666,532
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Voss Value Master Fund, LP | 3.00% | 699,440 |
| Voss Value-Oriented Special Situations Fund, LP | 1.30% | 316,768 |
| Voss Advisors GP, LLC | 4.30% | 1,016,208 |
| Voss Capital, LP | 11.30% | 2,666,532 |
| Cocke Travis W. | 11.30% | 2,666,532 |
Source
Related
- Rein Therapeutics, Inc.
- Voss Capital, LP
- Rein Therapeutics, Inc. shareholders
- Schedule 13G/A · Voss Capital, LP · Jul 14, 2026
- Schedule 13G/A · Voss Capital, LP · Feb 13, 2026
- Schedule 13G · Voss Capital, LP · May 14, 2025
- Schedule 13G/A · Lynwood Capital Management Inc. · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Laurence W. Lytton · Aug 13, 2026
- Form 4 · Von Rickenbach Josef H · May 28, 2026
- Form 4 · Windsor James Brian · May 13, 2026